ENNOGEN IP LTD
Executive Summary
ENNOGEN IP LTD operates as a niche player within the pharmaceutical manufacturing and wholesale sector, distinguished by a substantial intangible asset base indicative of significant intellectual property investment. While currently modestly profitable, the company’s financial structure and strategic positioning align with sector trends emphasizing innovation and integrated supply chain control. This positions ENNOGEN IP LTD well for growth, though it faces typical early-stage challenges competing in a capital-intensive and highly regulated industry.
View Full Analysis Report →- Legal registered address
- Unit G4 Riverside Way Dartford Riverside Way Dartford England DA1 5BS Copied!
Latest financial results as of 26 September 2025- Current assets
- £2.33m
- Fixed assets
- £8.65m
- Current creditors
- £2.02m
- Shareholders funds
- £9.00m
View full financial accounts- Current assets
- £2.33m
- Fixed assets
- £8.65m
- Current creditors
- £2.02m
- Shareholders funds
- £9.00m
- Company number
- 13266138 Copied!
Accounts
Latest annual accounts were to 31 December 2024
Next annual accounts are due by 30 September 2026
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 14 March 2025
Next statement due by 28 March 2026
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products
46460 - Wholesale of pharmaceutical goods
Latest company documents
Date | Description |
---|---|
25/09/2525 September 2025 New | Accounts for a small company made up to 2024-12-31 |
24/07/2524 July 2025 | Registration of charge 132661380002, created on 2025-07-17 |
22/07/2522 July 2025 | Satisfaction of charge 132661380001 in full |
19/06/2519 June 2025 | Appointment of Mr Roshan Ruprai as a director on 2025-06-16 |
19/06/2519 June 2025 | Appointment of Miss Nikisha Ruprai as a director on 2025-06-16 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company